Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute, J Natl Cancer Inst, vol.97, issue.13, pp.966-75, 2005. ,
Trends for inflammatory breast cancer: is survival improving? ,
, Oncologist, vol.12, issue.8, pp.12-20, 2007.
High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients, vol.12, pp.4614-4622, 2006. ,
Impact of estrogen receptorbeta expression on breast cancer prognosis: a meta-analysis, Breast Cancer Res Treat, vol.156, issue.1, pp.149-62, 2016. ,
Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women, BCR, vol.15, issue.5, p.90, 2013. ,
Outcomes of patients with inflammatory breast cancer by hormone receptor-and HER2-defined molecular subtypes: a population-based study from the SEER program, Oncotarget, 2017. ,
Chemotherapy response and survival of inflammatory breast cancer by hormone receptorand HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database, J Cancer Res Clin Oncol, vol.143, issue.1, pp.161-169, 2017. ,
Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor-and HER2-defined subtypes, Ann Oncol, vol.25, issue.2, pp.384-91, 2014. ,
Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets, Clin Cancer Res, vol.19, issue.17, pp.4685-96, 2013. ,
The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and bowel project protocol B-27, J Clin Oncol, vol.21, issue.22, pp.4165-74, 2003. ,
Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-values, Bioinformatics, vol.19, issue.10, pp.1236-1278, 2003. ,
Analysis of gene expression data using a linear mixed model/finite mixture model approach: application to regional differences in the human brain, Bioinformatics, vol.30, issue.11, pp.1555-61, 2014. ,
An introduction to recursive partitioning: rationale, application, and characteristics of classification and regression trees, bagging, and random forests, Psychol Methods, vol.14, issue.4, pp.323-371, 2009. ,
Prognostic and predictive significance of MYC and KRAS alterations in breast cancer from women treated with neoadjuvant chemotherapy, PLoS One, vol.8, issue.3, p.60576, 2013. ,
MYC overexpression with its prognostic and clinicopathological significance in breast cancer, Oncotarget, vol.8, issue.55, pp.93998-4008, 2017. ,
Correlation of MYC gene and Protein status with breast Cancer subtypes and outcome of patients treated with Anthracycline-based adjuvant chemotherapy. Pooled analysis of 2 Hellenic cooperative group phase III trials, Clinical breast cancer, vol.18, issue.1, pp.53-62, 2018. ,
MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours, Br J Cancer, vol.114, issue.8, pp.917-945, 2016. ,
Inflammatory breast cancer (IBC): clues for targeted therapies, Breast Cancer Res Treat, vol.140, issue.1, pp.23-33, 2013. ,
Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations, Breast Cancer Res Treat, vol.154, issue.1, pp.155-62, 2015. ,
Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers, Oncotarget, vol.6, issue.4, pp.2407-2420, 2015. ,
ERK/MAPK regulates ERRgamma expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer, FEBS J, vol.281, issue.10, pp.2431-2473, 2014. ,
Enhanced expression of the PDGFR/Abl signaling pathway in aromatase inhibitor-resistant breast cancer, Ann Oncol, vol.24, issue.1, pp.126-159, 2013. ,
Inflammatory breast cancer: unique biological and therapeutic considerations, Lancet Oncol, vol.16, issue.15, pp.146-147, 2015. ,
MYC on the path to cancer, Cell, vol.149, issue.1, pp.22-35, 2012. ,
8q24 Cancer risk allele associated with major metastatic risk in inflammatory breast cancer, PLoS One, vol.7, issue.5, p.37943, 2012. ,
Inflammatory breast cancer cells are characterized by attenuated SMAD dependent TGF? signaling leading to impaired cell motility responses. Paper presented at the 2018 San Antonio breast Cancer symposium, 2018. ,
, Publisher's Note
, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations